Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Antipsicóticos de nueva generación para el primer episodio de esquizofrenia

Información

DOI:
https://doi.org/10.1002/14651858.CD004410Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 20 octubre 2003see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Esquizofrenia

Copyright:
  1. Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Johannes Hamann

    Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, München, Germany

  • Werner Kissling

    Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, München, Germany

  • Stefan Leucht

    Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, München, Germany

  • Christine Rummel‐Kluge

    Correspondencia a: Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Leipzig, 04103 Leipzig, Germany

    [email protected]

Contributions of authors

Christine Rummel ‐ protocol development, searching, data extraction, analysis, data interpretation and writing the final report.

Johannes Hamann ‐ protocol development, data extraction, data checking, data interpretation.

Werner Kissling ‐ protocol development, data interpretation.

Stefan Leucht ‐ protocol development, searching, data extraction, data checking, data interpretation.

Sources of support

Internal sources

  • Freistaat Bayern, Germany.

External sources

  • German Federal Ministry for Education and Research (BMBF), Germany.

Declarations of interest

CR received lecture honoraria and/or travel grants to attend scientific meetings from Janssen‐Cilag, Eli Lilly and Pfizer. SL and WK received lecture honoraria and/or travel grants to attend scientific meetings from Janssen‐Cilag, Eli Lilly, Lundbeck, Pfizer, Sanofi‐Synthlabo and Zeneca. They also received financial support for a randomised trial from Eli Lilly, and for a meta‐analysis on amisulpride from Sanofi‐Synthelabo. WK received lecture honoraria form Novartis and BMS. JH received financial support to attend a scientific meeting from Janssen‐ Cilag.

Acknowledgements

We wish to thank the editorial base of the CSG for their continuous help.

Version history

Published

Title

Stage

Authors

Version

2003 Oct 20

New generation antipsychotics for first episode schizophrenia

Review

Johannes Hamann, Werner Kissling, Stefan Leucht, Christine Rummel‐Kluge

https://doi.org/10.1002/14651858.CD004410